IGF-BP5 Recombinant eiwit

IGF-BPs controls the distribution, function and activity of IGFs in various cell tissues and body fluids. Currently there are seven named IGF-BPs that form high affinity complexes with both IGF-I and IGF-II. IGF-BP5 is a 28.6 kDa cysteine-rich secreted protein produced by vascular smooth muscle cells. It is the major IGF-binding protein present in bone tissue and helps potentiate the action of IGF-I on smooth muscle cells, fibroblasts or osteoblasts. Data shows that IGFBP-5 acts as a growth inhibitor and pro-apoptotic agent in breast cancer cells. IGFBP-5 overexpressing mice show an increase in neonatal mortality, reduced female fertility, whole-body growth inhibition and retarded muscle development. Recombinant human IGF-BP5 is a 28.6 kDa protein consisting of 253 amino acid residues.

3488

P24593

NP_000590.1

Recombinant Proteins

E. coli

Apoptosis, Cancer, Cell Cycle, Signal Transduction, Other

Room Temp

The lyophilized IGF-BP5 recombinant protein is stable for at least 2 years from date of receipt at -20˚ C. Reconstituted IGF-BP5 is stable for at least 3 months when stored in working aliquots with a carrier protein at -20˚ C. As with any protein, exposing IGF-BP5 recombinant protein to repeated freeze / thaw cycles is not recommended. When working with proteins care should be taken to keep recombinant protein at a cool and stable temperature.

Insulin-like growth factor binding protein 5

Homo sapiens

IBP5, IBP5, Insulin-like growth factor-binding protein 5, IBP-5

Human

10834982

Lyophilized